Co-Authors
This is a "connection" page, showing publications co-authored by Cataldo Patruno and Giovanni Pellacani.
Connection Strength
0.178
-
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
Score: 0.060
-
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
Score: 0.060
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
Score: 0.058